Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Med Care. 2009 Jul;47(7 Suppl 1):S64–S69. doi: 10.1097/MLR.0b013e3181a23e25

Table 2.

Sample Characteristics for Approaches Used to Estimate Prevalence Costs of Care for Colorectal Cancer Patients

SEER-Medicare Medicare Claims
Only
MEPS

Number of CRC Patients 73,050 3,575 196

Number of Controls 146,100 17,875 12,152

Mean Age (years) 79.8 78.0

Gender (percent)
Male 44.3 42.2 45.0
Female 55.7 57.8 55.0

Stage Distribution at Diagnosis (percent)
In situ 7.3
Localized 46.2 N/A N/A
Regional 35.3
Distant 5.2
Unstaged/Missing 6.0

Mean/median survival months following
diagnosis or identification (months)
93.0/68.0 29.5/24.0 N/A
CRC patients 97.0/72.0 30.5/25.0
Controls

CRC = colorectal cancer SEER = Surveillance Epidemiology and End Results MEPS = Medical Expenditure Panel Survey N/A = Not available